Biggest News Aggregation in the World
📰 Bucillamine Phase News

Bucillamine Phase News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Bucillamine Phase. Real-time updates on events, politics, business and more.

Revive Therapeutics Announces Data Safety Monitoring Board Meeting Date on Phase 3 Clinical Study of Bucillamine in the Treatment of COVID-19

TORONTO, May 02, 2023 -- Revive Therapeutics Ltd. , a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, today... | May 2, 2023
Michael Frank Therapeutics Ltd Psilocin Pharma Corp Safety Monitoring Board Bucillamine Phase Orphan Drug

Revive Therapeutics Ltd says date set for independent Data and Safety Monitoring Board (DSMB) meeting for its Bucillamine Phase 3 clinical trial for COVID-19

Revive Therapeutics Ltd (CSE:RVV, OTCQB:RVVTF) has revealed that the independent Data and Safety Monitoring Board (DSMB) meeting for its Bucillamine Phase 3...
Michael Frank Psilocin Pharma Corp Therapeutics Ltd Drug Administration Revive Therapeutics Ltd Safety Monitoring Board

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science